moxonidine has been researched along with Breathlessness in 1 studies
moxonidine: structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Moxonidine treatment significantly reduced plasma noradrenaline concentration (P < 0." | 2.69 | Effects of sympathetic inhibition on exertional dyspnoea, ventilatory and metabolic responses to exercise in normotensive humans. ( De Vito, G; Galloway, SD; McClure, S; McMurray, JJ; Nimmo, MA, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Galloway, SD | 1 |
| De Vito, G | 1 |
| McClure, S | 1 |
| Nimmo, MA | 1 |
| McMurray, JJ | 1 |
1 trial available for moxonidine and Breathlessness
| Article | Year |
|---|---|
Effects of sympathetic inhibition on exertional dyspnoea, ventilatory and metabolic responses to exercise in normotensive humans.
Topics: Adult; Analysis of Variance; Antihypertensive Agents; Blood Pressure; Cross-Over Studies; Double-Bli | 2000 |